Apexigen
Apexigen is a biopharmaceutical company that develops and commercializes antibody-based immuno-oncology therapeutics for the treatment of cancer.
Business Model:
Revenue: $0
Employees: 11-50
Industries / Tags:
Detailed Apexigen Information
Apexigen was acquired by
Pyxis Oncology.
The acquisition happend on 2023-05-24.
Details of the transaction were not public
Acquirer
Geographic Data
Address: 75 Shoreway Road
City: San Carlos
State: CA
Zip: 94070
Country: US
Financial Info
Stage:
post ipo equity
Raised Last:
$3M
Raised Total:$161M
Social
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
Apexigen is a biopharmaceutical company that develops and commercializes antibody-based immuno-oncology therapeutics for the treatment of cancer.
Contact Phone:
+16509316236
Contact Email:
Apexigen went public on 8/1/2022 on the NASDAQ
Listed Exchange:
NASDAQ
IPO Date:
8/1/2022
IPO Valuation:
$205M
Ticker Symbol:
APGN
IPO Price:
$10/share
Amount Raised:
$58M
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
